FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular polynucleotides are presented, such as aptamers containing at least one first pyrimidine modified in the 5th position and at least one second pyrimidine modified in the 5th position, wherein the first and the second pyrimidines modified in the 5th position are different. Methods for selection and use of such polynucleotides, such as aptamers, are also presented.
EFFECT: invention allows for obtaining aptamer with improved stability.
59 cl, 22 dwg, 17 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
ADVANCED PROTEOMIC MULTIPLEX ANALYSIS | 2019 |
|
RU2792385C2 |
CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO | 2014 |
|
RU2732402C2 |
NUCLEIC ACID COMPOUNDS FOR BINDING GROWTH DIFFERENTIATION FACTOR 11 | 2015 |
|
RU2708170C2 |
COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
APTAMERIC THERAPEUTIC AGENTS APPLICABLE FOR TREATING COMPLEMENT-RELATED DISORDERS | 2006 |
|
RU2406507C2 |
TARGET RNA EDITING | 2015 |
|
RU2711506C2 |
SELF-DELIVERED RNAI COMPOUNDS OF REDUCED SIZE | 2011 |
|
RU2615143C2 |
PCSK9 ANTAGONISTS | 2009 |
|
RU2528735C2 |
PCSK9 ANTAGONISTS | 2014 |
|
RU2618869C2 |
NEW CONNECTING C5a NUCLEIC ACIDS | 2013 |
|
RU2645261C2 |
Authors
Dates
2021-12-29—Published
2017-06-30—Filed